Avantor (AVTR) Other Non-Current Liabilities (2018 - 2026)
Avantor (AVTR) recorded quarterly Other Non-Current Liabilities of $377.3 million in Q1 2026, little changed quarter-over-quarter from $378.2 million in Q4 2025, and up 3.48% on a YoY basis from $364.6 million in Q1 2025.
Avantor (AVTR) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
Avantor's Other Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $377.3 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 3.48% year-over-year to $377.3 million; the TTM figure through Mar 2026 stood at $377.3 million (up 3.48% YoY), while the FY2025 annual figure was $378.2 million, up 5.55% from the prior year.
- Other Non-Current Liabilities was $377.3 million for Q1 2026 at Avantor, roughly flat from $378.2 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $418.9 million in Q3 2024 to a low of $268.8 million in Q2 2023.
- Historically, Other Non-Current Liabilities has averaged $349.8 million across 5 years, with a median of $360.7 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities retreated 23.55% in 2023, then soared 54.4% in 2024.
- A 5-year view of Other Non-Current Liabilities shows it stood at $295.4 million in 2022, then climbed by 18.58% to $350.3 million in 2023, then gained by 2.28% to $358.3 million in 2024, then increased by 5.55% to $378.2 million in 2025, then retreated by 0.24% to $377.3 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $377.3 million (Q1 2026), $378.2 million (Q4 2025), and $402.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Avantor | 6.47 Bn | 6.19 Bn | 500.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 377.30 Mn |
| Dec 31, 2025 | 378.20 Mn |
| Sep 30, 2025 | 402.60 Mn |
| Jun 30, 2025 | 391.40 Mn |
| Mar 31, 2025 | 364.60 Mn |
| Dec 31, 2024 | 358.30 Mn |
| Sep 30, 2024 | 418.90 Mn |
| Jun 30, 2024 | 361.90 Mn |
| Mar 31, 2024 | 360.70 Mn |
| Dec 31, 2023 | 350.30 Mn |
| Sep 30, 2023 | 271.30 Mn |
| Jun 30, 2023 | 268.80 Mn |
| Mar 31, 2023 | 300.10 Mn |
| Dec 31, 2022 | 295.40 Mn |
| Sep 30, 2022 | 334.10 Mn |
| Jun 30, 2022 | 351.60 Mn |
| Mar 31, 2022 | 361.10 Mn |
| Dec 31, 2021 | 358.40 Mn |
| Sep 30, 2021 | 403.00 Mn |
| Jun 30, 2021 | 411.60 Mn |